Dexamethasone Sodium Phosphate 6 mg/25 ml
Product Details
- Ready-to-administer Dexamethasone bag, no need for mixing or diluting
- Dosed at 6 mg in 25 mL
- The National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel1 and the World Health Organization (WHO)2 updated their recommendations to include systemic corticosteroids, like Dexamethasone 6 mg daily, for hospitalized patients with severe and critical COVID-19
- Manufactured in a 503B cGMP facility with a certificate of analysis for each lot
PRODUCT #
PRODUCT DESCRIPTION
PRODUCT SOURCE
BUD
(DAYS)
(DAYS)
CASE
QUANTITY
QUANTITY
70092961835
Dexamethasone 6 mg (0.24 mg/ml) in 25 ml 0.9 % Sodium Chloride Solution- 50 ml IntraVia Bag
API to Sterile
90
12
1 National Institutes of Health. (2020, August 27). NIH COVID-19 Treatment Guidelines. https://www.covid19treatmentguidelines.nih.gov/immune-based-therapy/immunomodulators/corticosteroids.
2World Health Organization. (2020, September 2). WHO updates clinical care guidance with corticosteroid recommendations. https://www.who.int/news-room/feature- stories/detail/who-updates-clinical-care-guidance-with-corticosteroid-recommendations.